π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
QL1706 Combined with Lenvatinib and GEMOX as First - Line Treatment for Unr...
Status
Active Not Recruiting
Location
the Third Affiliated Hospital of Naval Medical University
Start Date
2025-06-14
Trial ID
NCT06892925
Treatments Being Tested
The purpose of this study is to learn how well a combination of iparomlimab...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Start Date
2026-10-01
Trial ID
NCT07776080
This is a single-arm, multicenter, exploratory clinical study evaluating th...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2025-08-11
Trial ID
NCT07131501
Treatments Being Tested
Study Design Prospective, single-arm, multicenter clinical study. Study Dr...
Status
Not Yet Recruiting
Location
Nanjing Drum Tower Hospital
Start Date
2026-08-15
Trial ID
NCT07741617
Treatments Being Tested
The investigators plan to initiate a prospective, multicenter, phase II stu...
Status
Recruiting
Location
Nanjing Drum Tower Hospital
Start Date
2025-09-03
Trial ID
NCT07110064
Treatments Being Tested
This study will evaluate the efficacy and safety of cryoablation combined w...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-08-20
Trial ID
NCT07070700
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of QL1706 pl...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06746961
Treatments Being Tested
This phase II clinical study aims to evaluate the efficacy and safety of QL...
Status
Recruiting
Location
Sun Yat-Sen University Cancer Center
Start Date
2026-04-10
Trial ID
NCT07384416
Treatments Being Tested
Through the combination of aparolitovorelli monoclonal antibody and lenvati...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-21
Trial ID
NCT07389629
Treatments Being Tested